Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus

Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus

Released Thursday, 24th July 2025
Good episode? Give it some love!
Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus

Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus

Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus

Rebecca Fitzgerald on biomarker risk stratification with capsule sponge in the surveillance of Barrett's oesophagus

Thursday, 24th July 2025
Good episode? Give it some love!
Rate Episode
List

Early detection of oesophageal adenocarcinoma improves outcomes. Patients with the precursor lesion, Barrett's oesophagus, are recommended to undergo regular endoscopic surveillance, a process that can be burdensome for patients and health services. 

Professor Rebecca Fitzgerald's team have developed a tool that may be able to improve Barrett's surveillance. She joins us to discuss her recent prospective real-world implementation study of capsule sponge risk stratification in Barrett’s oesophagus surveillance in the UK.

Read the full article:

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01021-9/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lancet

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Show More